NCT00002008View on ClinicalTrials.gov

An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV InfectionsCytopenias
Interventions
DRUG

Sargramostim

Trial Locations (2)

90095

UCLA CARE Ctr, Los Angeles

02215

Beth Israel Deaconess - West Campus, Boston

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00002008 - An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia | Biotech Hunter | Biotech Hunter